Mixed Hyperbilirubinemia
Overview
Plain-Language Overview
Mixed hyperbilirubinemia is a condition where there is an increase in both direct (conjugated) and indirect (unconjugated) bilirubin in the blood. Bilirubin is a yellow pigment produced when the body breaks down old red blood cells, and it is normally processed by the liver before being excreted. When this process is disrupted, bilirubin builds up, causing jaundice, which is a yellowing of the skin and eyes. This condition affects the liver and bile system, impacting how the body removes waste products. Mixed hyperbilirubinemia can signal underlying problems such as liver disease, bile duct obstruction, or hemolysis. It is important because it reflects a combination of issues with bilirubin production and clearance, which can affect overall health.
Clinical Definition
Mixed hyperbilirubinemia is defined as an elevation of both conjugated (direct) and unconjugated (indirect) bilirubin fractions in the serum, indicating a combination of hepatocellular dysfunction and impaired bilirubin clearance or increased bilirubin production. The core pathology involves simultaneous impaired hepatic conjugation or excretion and excessive bilirubin production or impaired uptake. Common causes include hepatitis, cirrhosis, biliary obstruction, and hemolytic anemias. This condition is clinically significant as it often reflects complex liver or hematologic disease processes that require thorough evaluation. The presence of mixed hyperbilirubinemia suggests both intrahepatic cholestasis and hemolysis or impaired bilirubin metabolism. It is a key diagnostic clue in differentiating types of jaundice and guiding further workup.